Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × apatinib × Tumor-Agnostic × Clear all

Phase

Status

Completed 5 Active not recruiting 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 104 Thoracic 38 Head & Neck 18 Gynecologic 15 Sarcoma 14 Breast 13 CNS 7 Lymphoid 4 Dermatologic 4 Other solid neoplasm 3 Tumor-Agnostic 1 Genitourinary 1 Endocrine 1

Conditions

Interventions

Radiotherapy 9 Cisplatin 9 Gemcitabine 7 Drug Therapy 7 Blood Specimen Collection 7 Fluorouracil 6 Docetaxel 6 Carboplatin 6 Capecitabine 6 Pemetrexed 5 Nivolumab 5 Trastuzumab 4 Positron Emission Tomography Computed Tomography 4 Paclitaxel 4 Oxaliplatin 4 Everolimus 4 Cetuximab 4 Biopsy 4 pembrolizumab 3 indibulin 3 icotinib 3 Surveys and Questionnaires 3 Standard of Care 3 Radiosurgery 3 Neoadjuvant Therapy 3 Magnetic Resonance Spectroscopy 3 Interleukin-2 3 Immune Checkpoint Inhibitors 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 Gallium-68 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00633490 2008-07-22

Study of Apatinib as an Inhibitor of Tumor Angiogenesis

Fudan University

Phase 1 Unknown

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡